Measure: CMS2
Preventive Care and Screening: Screening for Depression and Follow-Up Plan
Measure Versions
| eMeasure Code |
Measure Year |
Full Version Number |
Title |
| CMS2v13 |
2024 |
13.1.000 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
| CMS2v12 |
2023 |
12 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
| CMS2v11 |
2022 |
11.0.000 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
| CMS2v10 |
2021 |
10.2.000 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
| CMS2v9 |
2020 |
9.1.000 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
| CMS2v8 |
2019 |
8.1.000 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
| CMS2v7 |
2018 |
7.1.000 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
| CMS2v6 |
2017 |
6.3.000 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Description
Percentage of patients aged 12 years and older screened for depression on the date of the encounter using an age appropriate standardized depression screening tool AND if positive, a follow-up plan is documented on the date of the positive screen
Guidance
A depression screen is completed on the date of the encounter using an age appropriate standardized depression screening tool AND if positive, a follow-up plan is documented on the date of the positive screen.
Screening Tools:
* The name of the age appropriate standardized depression screening tool utilized must be documented in the medical record
* The depression screening must be reviewed and addressed in the office of the provider, filing the code, on the date of the encounter
* The screening and encounter must occur on the same date
* Standardized Depression Screening Tools should be normalized and validated for the age appropriate patient population in which they are used and must be documented in the medical record
Follow-Up Plan:
* The follow-up plan must be related to a positive depression screening, example: "Patient referred for psychiatric evaluation due to positive depression screening."
Patient Group Definitions
| Group |
Description |
Instructions Links |
| Initial Population | All patients aged 12 years and older before the beginning of the measurement period with at least one eligible encounter during the measurement period | Webchart Instructions |
| Denominator | Equals Initial Population | Webchart Instructions |
| Denominator Exclusions | Patients with an active diagnosis for Depression or a diagnosis of Bipolar Disorder | Webchart Instructions |
| Numerator | Patients screened for depression on the date of the encounter using an age appropriate standardized tool AND if positive, a follow-up plan is documented on the date of the positive screen | Webchart Instructions |
| Numerator Exclusions | Not Applicable | Webchart Instructions |
| Denominator Exceptions | Patient Reason(s)
Patient refuses to participate
OR
Medical Reason(s)
Patient is in an urgent or emergent situation where time is of the essence and to delay treatment would jeopardize the patient's health status
OR
Situations where the patient's functional capacity or motivation to improve may impact the accuracy of results of standardized depression assessment tools. For example: certain court appointed cases or cases of delirium | Webchart Instructions |
Details
| Full eMeasure Code |
eMeasure Identifier |
Measure Year |
Version |
NQF # |
GUID |
| CMS2v6 |
2 |
2017 |
6.3.000 |
0418 |
9a031e24-3d9b-11e1-8634-00237d5bf174 |
| Steward |
Developer |
Endorsed By |
| Quality Insights of Pennsylvania |
Centers for Medicare & Medicaid Services (CMS) |
National Quality Forum |
| Scoring Method |
Measure Type |
Stratification |
Risk Adjustment |
| Proportion |
PROCESS |
None |
None |
Rate Aggregation
None
Improvement Notation
Higher score indicates better quality
Rationale
In 2008, the Geriatric Mental Foundation reported that of the population aged 65 and older in the United States, 15-20 percent of adults had experienced depression (Geriatric Mental Health Foundation, 2008), while 7 million of the same population were affected by depression (Steinman, 2007, p. 175) and accounted for 16 percent of suicide deaths in 2004 (Centers for Disease Control and Prevention, 2007).
The World Health Organization (WHO), as cited by Pratt & Brody (2008), found that major depression was the leading cause of disability worldwide. "Overall, approximately 80% of persons with depression reported some level of difficulty in functioning because of their depressive symptoms. In addition, 35% of males and 22% of females with depression reported that their depressive symptoms make it very or extremely difficult for them to work, get things done at home, or get along with other people. More than one-half of all persons with mild depressive symptoms also reported some difficulty in daily functioning attributable to their symptoms" (Pratt & Brody, 2008, p.2). Pratt & Brody (2008) found that depression rates were higher in the 40-59 age brackets, is more common in females than in males, and higher in non- Hispanic black persons than in their non-Hispanic white counterparts (Pratt & Brody, 2008, p. 2). Disparities due to income have also been observed, as those with lower income (below the federal poverty line) in the 18-39 and 40-59 age brackets, whom experience higher depression rates than those with higher income. This disparity is not observable in other age categories (Pratt & Brody, 2008, p. 2).
Among children, the rate of current or recent depression stands at 3% and at 6% for adolescents, whose lifetime incidence rate of major depressive disorder (MDD) could be as high as 20% (Williams et al., 2009, p. e716). Borner (2010), states that 20% of adolescents are likely to have experienced depression by the time they are 18 years old and that there is an observed increased onset around puberty. Onset of MDD during adolescence is particularly significant because it is associated with higher risks of suicide attempt, death by suicide and MDD recurrence in young adulthood. Additionally MDD is "associated with early pregnancy, decreased school performance, and impaired work, social, and family functioning during young adulthood" (Williams et al., 2009, p. e716). According to Zalsman et al., (2006) as reported in Borner et al. (2010), "depression ranks among the most commonly reported mental health problems in adolescent girls" (p. 947).
"The negative outcomes associated with early onset depression, make it crucial to identify and treat depression in its early stages" (Borner, 2010, p. 948). While Primary Care Providers (PCPs) serve as the first line of defense in the detection of depression, studies show that PCPs fail to recognize up to 50% of depressed patients, purportedly because of time constraints and a lack of brief, sensitive, easy-to administer psychiatric screening instruments" (Borner, 2010, p. 948). "Coyle et al. (2003), suggested that the picture is more grim for adolescents, and that more than 70% of children and adolescents suffering from serious mood disorders go unrecognized or inadequately treated" (Borner, 2010, p. 948).
The substantial economic burden of depression for individuals and society alike makes a case for screening for depression on a regular basis. This measure seeks to achieve this goal and aligns with the Healthy People 2020 recommendation for routine screening for mental health problems as a part of primary care for both children and adults (U.S. Department of Health and Human Services, 2014). The measure makes important contribution to the quality domain of community and population health.
Clinical Recommendation Statement
Adolescent Recommendation (12-18 years):
"The USPSTF recommends screening of adolescents (12-18 years of age), for major depressive disorder (MDD) when systems are in place to ensure accurate diagnosis, psychotherapy (cognitive-behavioral or interpersonal), and follow-up" (AHRQ, 2010, p.141).
"Clinicians and health care systems should try to consistently screen adolescents, ages 12-18, for major depressive disorder, but only when systems are in place to ensure accurate diagnosis, careful selection of treatment, and close follow-up" (ICSI, 2013, p. 16).
Adult Recommendation (18 years and older):
"The USPSTF recommends screening adults for depression when staff-assisted depression care supports are in place to assure accurate diagnosis, effective treatment, and follow-up" (AHRQ, 2010, p.136).
"A system that has embedded the elements of best practice and has capacity to effectively manage the volume, should consider routine screening of all patients based on the recommendations of the U.S. Preventive Services Task Force" (ICSI, 2013, p. 7). "Clinicians should use a standardized instrument to screen for depression if it is suspected, based on risk factors or presentation. Clinicians should assess and treat for depression in patients with some comorbidities. Clinicians should acknowledge the impact of culture and cultural differences on physician and mental health. Clinicians should screen and monitor depression in pregnant and post-partum women" (ICSI, 2013, p. 4).
Definition
Screening:
Completion of a clinical or diagnostic tool used to identify people at risk of developing or having a certain disease or condition, even in the absence of symptoms.
Standardized Depression Screening Tool - A normalized and validated depression screening tool developed for the patient population in which it is being utilized
Examples of depression screening tools include but are not limited to:
* Adolescent Screening Tools (12-17 years)
* Patient Health Questionnaire for Adolescents (PHQ-A)
* Beck Depression Inventory-Primary Care Version (BDI-PC)
* Mood Feeling Questionnaire(MFQ)
* Center for Epidemiologic Studies Depression Scale (CES-D)
* Patient Health Questionnaire (PHQ-9)
* Pediatric Symptom Checklist (PSC-17)
* PRIME MD-PHQ2
* Adult Screening Tools (18 years and older)
* Patient Health Questionnaire (PHQ9)
* Beck Depression Inventory (BDI or BDI-II)
* Center for Epidemiologic Studies Depression Scale (CES-D)
* Depression Scale (DEPS)
* Duke Anxiety-Depression Scale (DADS)
* Geriatric Depression Scale (SDS)
* Cornell Scale Screening
* PRIME MD-PHQ2
Follow-Up Plan:
Documented follow-up for a positive depression screening must include one or more of the following:
* Additional evaluation for depression
* Suicide Risk Assessment
* Referral to a practitioner who is qualified to diagnose and treat depression
* Pharmacological interventions
* Other interventions or follow-up for the diagnosis or treatment of depression
Transmission Format
TBD
Applicable Value Sets
| Category |
Value Set |
OID |
|
Negative Depression Screening |
2.16.840.1.113883.3.600.2451 |
|
Positive Depression Screening |
2.16.840.1.113883.3.600.2450 |
| Diagnosis |
Bipolar Diagnosis |
2.16.840.1.113883.3.600.450 |
| Diagnosis |
Depression diagnosis |
2.16.840.1.113883.3.600.145 |
| Encounter, Performed |
Depression Screening Encounter Codes |
2.16.840.1.113883.3.600.1916 |
| Intervention, Order |
Referral for Depression Adolescent |
2.16.840.1.113883.3.600.537 |
| Intervention, Order |
Referral for Depression Adult |
2.16.840.1.113883.3.600.538 |
| Intervention, Performed |
Additional evaluation for depression - adolescent |
2.16.840.1.113883.3.600.1542 |
| Intervention, Performed |
Additional evaluation for depression - adult |
2.16.840.1.113883.3.600.1545 |
| Intervention, Performed |
Follow-up for depression - adolescent |
2.16.840.1.113883.3.600.467 |
| Intervention, Performed |
Follow-up for depression - adult |
2.16.840.1.113883.3.600.468 |
| Medication, Order |
Depression medications - adolescent |
2.16.840.1.113883.3.600.469 |
| Medication, Order |
Depression medications - adult |
2.16.840.1.113883.3.600.470 |
| Patient Characteristic Ethnicity |
Ethnicity |
2.16.840.1.114222.4.11.837 |
| Patient Characteristic Payer |
Payer |
2.16.840.1.114222.4.11.3591 |
| Patient Characteristic Race |
Race |
2.16.840.1.114222.4.11.836 |
| Patient Characteristic Sex |
ONC Administrative Sex |
2.16.840.1.113762.1.4.1 |
| Procedure, Performed |
Suicide Risk Assessment |
2.16.840.1.113883.3.600.559 |
| Risk Category Assessment |
Adolescent Depression Screening |
2.16.840.1.113883.3.600.2452 |
| Risk Category Assessment |
Adult Depression Screening |
2.16.840.1.113883.3.600.2449 |
| Risk Category Assessment |
Medical or Other reason not done |
2.16.840.1.113883.3.600.1.1502 |
| Risk Category Assessment |
Patient Reason refused |
2.16.840.1.113883.3.600.791 |
References
Pratt L.A, Brody DJ.(2008). Depression in the United States household population, 2005-2006. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention National Center for Health Statistics. NCHS Data Brief No.7, 1-8.
Borner I, Braunstein JW, St. Victor, R, Pollack J (2010). Evaluation of a 2-question screening tool for detecting depression in adolescents in Primary Care. Clinical Pediatrics, 49, 947-995. doi: 10.1177/0009922810370203
Coyle J T, Pine D.S, Charney D S, Lewis L, Nemeroff C B, Carlson G A, Joshi P T (2003). Depression and bipolar support alliance consensus development panel. Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1494-1503.
U.S. Department of Health and Human Services (2014). Healthy People 2020. Washington, DC: U.S. Department of Health and Human Services. Retrieved from: http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=28
Williams SB. O'Connor EA, Eder M, Whitlock EP (2009). Screening for Child and Adolescent Depression in Primary Care Setting: A Systematic Evidence Review for the US Preventive Services Task Force. Pediatrics, 123, e716-e735. doi:10.1542/peds.2008-2415
Zalsman G, Brent DA & Weersing VR (2006). Depressive disorders in childhood and adolescence: an overview: epidemiology, clinical manifestation and risk factors. Child Adolesc Psychiatr Clin N Am. 2006;15:827-841
Agency for Healthcare Research and Quality (2010). The Guide to Clinical Preventive Services 2010-2011: Recommendations of the U.S. Preventive Services Task Force. Retrieved from: http://www.ncbi.nlm.nih.gov/books/NBK56707/
Wilkinson J, Bass C, Diem S, Gravley A, Harvey L, Maciosek M, McKeon K, Milteer L, Owens J, Rothe P, Snellman L, Solberg L, Vincent P. Institute for Clinical Systems Improvement. Preventive Services for Children and Adolescents. Updated September 2013. https://www.icsi.org/_asset/x1mnv1/PrevServKids.pdf
Centers for Disease Control and Prevention (2007). Web-based injury statistics query and reporting system (WISQARS), National Center for Injury Prevention and Control, 2005. Retrieved from: http://www.cdc.gov/injury/wisqars/index.html
Geriatric Mental Health Foundation (2008). Depression in late life: not a natural part of aging, 2008. Retrieved from: http://www.aagponline.org/index.php?src=gendocs&ref=depression&category=Foundation
Steinman LE, Frederick JT, Prohaska T, Satariano WA, Dornberg-Lee S, Fisher R, ...Snowden M (2007). Recommendations for treating depression in community-based older adults. American Journal of Preventive Medicine, 33(3), 175-81. Retrieved from: www.ajpm-online.net/article/S0749-3797%2807%2900330-3/abstract
Mitchell J, Trangle M, Degnan B, Gabert T, Haight B, Kessler D, Mack N, Mallen E, Novak H, Rossmiller D, Setterlund L, Somers K, Valentino N, Vincent S. Institute for Clinical Systems Improvement. Adult Depression in Primary Care. Updated September 2013. https://www.icsi.org/_asset/fnhdm3/Depr.pdf
Disclaimer
These performance measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications.
THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND.
Copyright
Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. Quality Insights of Pennsylvania disclaims all liability for use or accuracy of any Current Procedural Terminology (CPT [R]) or other coding contained in the specifications.
CPT (R) contained in the Measure specifications is copyright 2007-2016 American Medical Association.
LOINC (R) copyright 2004-2015 [2.50] Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms (R) (SNOMED CT [R]) copyright 2004-2015 [2014-09] International Health Terminology Standards Development Organization. All Rights Reserved.
Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].
Source:
https://ecqi.healthit.gov/ecqm/measures/cms2v6